CLINICAL EVALUATION OF DL-8280
スポンサーリンク
概要
- 論文の詳細を見る
Chemotherapeutic efficacy of DL-8280 was studied in 14 cases. These cases consisted of 9 cases of acute or chronic respiratory tract infection, 4 cases of acute or chronic urinary tract infection and 1 case of bile duct infection.<BR>DL-8280 was given orally to the patients at the dose of 200 to 300 mg per day for 6 to 16 days.<BR>The clinical effectiveness was determined routinely. That was excellent in 5 cases (35.7%), good in 7 cases (50%) and poor in 2 cases (14.3%). The rate of effectiveness of DL-8280 in our studies was 85.7%.<BR>There was no side effect in these cases.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.